Supply of Cladribine (Mavenclad®)
A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- 24.5 month
- Value
- £4M-£31M
- Sector
- HEALTH
- Published
- 21 Jan 2022
- Delivery
- 12 Feb 2018 to 28 Feb 2020
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Merck Serono Feltham
Description
This procurement is for the supply of Cladribine (Mavenclad®) to NHSScotland.
Ammendments to Previous Notice
2. Contract value
GBP 28,274,680 31,102,148
Award Detail
| 1 | Merck Serono (Feltham)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract modified due to unforeseen circumstances.
Legal Justification
This modification of contract term from 01/03/2022 to 31/08/2022 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots.
Other Information
The total value in Section II.1.7 and V.2.4 refers to the twenty four (24) months initial duration and the full twenty four (24) month extension option. (SC Ref:679428)
Reference
- OJEU 036896-2022